Latest news
Activatable Antibodies in Targeted Therapies
Brain Glycogen and Neurodegenerative Diseases
Interview with Oriol Martínez Huguet, CEO of GasN2
IQS Teaches its First Bioprocesses Course for Companies
7 QUESTIONS FOR… Gilda Hernández
Hausmann, New Member of the IQS Business Foundation
Introducing Our New Website!
Analysis of Neurotoxic Compounds in Water. COGNIRISK Project
New Synthesis Challenges. BISiboNds Project